In hPDGFb-induced gliomas, pharmacologic blockade by the PDGFR/VEGFR inhibitor PTK787 that crosses the blood-brain barrier results in cell cycle arrest of the tumor cells; thus, these gliomas retain their dependence on PDGFR signaling [39]. This evidence concerns the gene KDR and neoplasm.